These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 16933372)
1. FDA clears HIV drug for patients with resistant virus. AIDS Read; 2006 Aug; 16(8):392. PubMed ID: 16933372 [No Abstract] [Full Text] [Related]
2. Lower dose of ritonavir approved for use with fosamprenavir. Sax PE AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004 [No Abstract] [Full Text] [Related]
3. FDA approves new dosing for amprenavir and ritonavir combination. AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920 [No Abstract] [Full Text] [Related]
4. FDA notifications. Potential serious effect of combination saquinavir-ritonavir. AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774 [No Abstract] [Full Text] [Related]
5. Darunavir now approved for use in treatment-naive patients. Sax PE AIDS Clin Care; 2008 Dec; 20(12):102. PubMed ID: 19271337 [No Abstract] [Full Text] [Related]
6. New HIV treatment. FDA Consum; 2006; 40(5):7. PubMed ID: 17326304 [No Abstract] [Full Text] [Related]
7. FDA notifications. FDA approves NDA for Lexiva. AIDS Alert; 2007 Dec; 22(12):142. PubMed ID: 18415960 [No Abstract] [Full Text] [Related]
9. TMC114 approved for resistant patients. AIDS Patient Care STDS; 2006 Oct; 20(10):731. PubMed ID: 17052143 [No Abstract] [Full Text] [Related]
10. FDA notifications. FDA OKs new pediatric dosing for darunavir. AIDS Alert; 2009 Feb; 24(2):22-4. PubMed ID: 19222149 [No Abstract] [Full Text] [Related]